Fecal calprotectin is a protein released by white blood cells during intestinal inflammation; it helps distinguish inflammatory bowel disease from irritable bowel syndrome.
Calprotectin im Stuhl is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Calprotectin im Stuhl is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
Calprotectin im Stuhl does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Fecal calprotectin is a calcium- and zinc-binding protein found primarily inside neutrophils, a type of white blood cell. When the lining of the intestines becomes inflamed, neutrophils migrate to the gut and release calprotectin into the stool. Because it is stable in feces and can be measured easily, calprotectin has become a widely used non-invasive marker for intestinal inflammation.
A calprotectin level below the laboratory’s defined cut-off (often <50 µg/g of stool, equivalent to <50 mg/kg, though ranges are lab-dependent) is considered normal. This finding generally makes active intestinal inflammation unlikely. It supports a diagnosis of a functional bowel disorder such as irritable bowel syndrome rather than inflammatory bowel disease.
Occasionally, extremely low values may be seen when there is a lack of neutrophils or a compromised immune system, but this is rarely clinically significant.
An elevated fecal calprotectin level (typically >50–120 µg/g, lab-dependent) indicates the presence of neutrophils in the intestinal tract, pointing to active inflammation. This is commonly seen in inflammatory bowel disease (Crohn’s disease, ulcerative colitis), but can also occur with gastrointestinal infections, diverticulitis, colorectal cancer, or use of non-steroidal anti-inflammatory drugs (NSAIDs).
The degree of elevation often correlates with the severity of inflammation, and repeated measurements can be used to monitor disease activity or response to therapy.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
You collect a small sample of stool at home using a provided kit and return it to the lab. No special diet or fasting is required. The sample is then analyzed to measure calprotectin concentration, and results are usually available within a few days.
Calprotectin im Stuhl is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Fecal Calprotectin (FC) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
A normal fecal calprotectin level varies between laboratories but is usually less than 50 micrograms per gram of stool (µg/g; also expressed as 50 mg/kg). Some labs use a cut-off of up to 120 µg/g for older adults. Always interpret your result with the range provided by your testing laboratory.
A high calprotectin level suggests active inflammation in the intestines. It is often associated with inflammatory bowel disease (IBD), but bacterial or viral gut infections, certain medications, and other conditions can also raise it. Further testing, such as colonoscopy, is usually required to pinpoint the exact cause.
There is no danger in having a very low calprotectin level; it simply indicates that there is no significant neutrophil-driven inflammation in the gut at the time of testing. This is a reassuring finding that makes conditions like Crohn’s disease or ulcerative colitis unlikely.
Calprotectin im Stuhl does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
This biomarker gains value when it is connected to symptom patterns, daily function, and structured self-observation instead of being read in isolation.
Reduced capacity, multisystem symptoms, and delayed worsening often make more sense when the broader ME/CFS pattern is considered.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
